GTR 112252629
Tenders Are Invited For Pharmaceutical Products – Purchase Of Iron Carboxymaltose, Paclitaxel (Nanoparticles Bound To Albumin), Nilotinib, Axitinib, Pazopanib, Tocilizumab, Pomalidomide, Denosumab And Esketamine
ICB — International Competitive Bid
Closed
Western Europe
Tender Information
GTR Reference
112252629
Tendering Authority
Subscribe to view
Tender No
281896-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Purchase Of Iron Carboxymaltose, Paclitaxel (Nanoparticles Bound To Albumin), Nilotinib, Axitinib, Pazopanib, Tocilizumab, Pomalidomide, Denosumab And Esketamine
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union
Last Date of Bid Submission
26-05-2026
Closed
Work Detail
Pharmaceutical Products – Purchase Of Iron Carboxymaltose, Paclitaxel (Nanoparticles Bound To Albumin), Nilotinib, Axitinib, Pazopanib, Tocilizumab, Pomalidomide, Denosumab And Esketamine. Iron Carboxymaltose,Paclitaxel Nanoparticles Bound To Albumin,Nilotinib,Axitinib,Pazomanib,Tocilizumab,Pomalidomide,Denosumab 60Mg,Denosumab 120Mg,Sketching
Key Value
Tender Value
7,129,200 - EUR
Tender Documents
Global Tender Document
60a82ff5-ca0d-4a3f-bc72-86bfe6587fea.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.